Telix boosts in-house ra­dio­phar­ma man­u­fac­tur­ing; Dy­navax im­proves vac­cine pro­duc­tion costs

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more.

Telix Phar­ma­ceu­ti­cals is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER